Anne Marie Bickmore - 03 May 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: COO and Chief Product Officer
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 03 May 2023
Net transactions value: $0
Form type: 4
Filing time: 04 May 2023, 16:33:13 UTC
Previous filing: 13 Apr 2023
Next filing: 05 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Award	$0	+35,000	+96%	$0.000000	71,271	03 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Content

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.